American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, CooperDS, DohertyGM, HaugenBR, KloosRT, LeeSL, MandelSJ, MazzaferriEL, McIverB, PaciniF, SchlumbergerM, ShermanSI, StewardDL, TuttleRM. 2009. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.
2.
MorrisLG, SikoraAG, TostesonTD, DaviesL. 2013. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid, 23:885–891.
3.
HaoY, JemalA, ZhangX, WardEM. 2009. Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States). Cancer Causes Control, 20:1855–1863.
4.
HaymartMR, BanerjeeM, StewartAK, KoenigRJ, BirkmeyerJD, GriggsJJ. 2011. Use of radioactive iodine for thyroid cancer. JAMA, 306:721–728.
5.
HaymartMR, BanerjeeM, YangD, StewartAK, KoenigRJ, GriggsJJ. 2013. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer, 119:259–265.
6.
HaymartMR, BanerjeeM, YangD, StewartAK, SissonJC, KoenigRJ, DohertyGM, GriggsJJ. 2013. Variation in the management of thyroid cancer. J Clin Endocrinol Metab, 98:2001–2008.
